TFS Capital’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-55,416
| Closed | -$903K | – | 352 |
|
|
2017
Q2 | $903K | Sell |
55,416
-21,572
| -28% | -$352K | 0.35% | 66 |
|
|
2017
Q1 | $1.08M | Sell |
76,988
-12,727
| -14% | -$178K | 0.35% | 82 |
|
|
2016
Q4 | $1.43M | Buy |
89,715
+2,885
| +3% | +$46K | 0.38% | 63 |
|
|
2016
Q3 | $1.45M | Buy |
86,830
+68,044
| +362% | +$1.13M | 0.35% | 105 |
|
|
2016
Q2 | $210K | Buy |
+18,786
| New | +$210K | 0.04% | 716 |
|
|
2016
Q1 | – | Sell |
-77,342
| Closed | -$720K | – | 1101 |
|
|
2015
Q4 | $720K | Sell |
77,342
-44,592
| -37% | -$415K | 0.08% | 354 |
|
|
2015
Q3 | $1.38M | Buy |
121,934
+50,442
| +71% | +$569K | 0.13% | 248 |
|
|
2015
Q2 | $907K | Sell |
71,492
-60,822
| -46% | -$772K | 0.09% | 363 |
|
|
2015
Q1 | $1.23M | Buy |
+132,314
| New | +$1.23M | 0.12% | 272 |
|